287 related articles for article (PubMed ID: 8166483)
1. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
Bech-Thomsen N; Angelo HR; Wulf HC
Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
Cox NH; Farr PM; Diffey BL
Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
[TBL] [Abstract][Full Text] [Related]
3. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
Stern RS; Momtaz K
Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
[TBL] [Abstract][Full Text] [Related]
4. Minimum erythema dose determination in individuals of skin type V and VI with diffuse reflectance spectroscopy.
Kollias N; Baqer A; Sadiq I
Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):249-54. PubMed ID: 7727281
[TBL] [Abstract][Full Text] [Related]
5. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
6. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
[TBL] [Abstract][Full Text] [Related]
7. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Al-Ismail D; Edwards C; Anstey AV
Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous phototoxicity due to psoralens.
Gange RW; Parrish JA
Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
[TBL] [Abstract][Full Text] [Related]
9. The effect of methoxsalen dose on ultraviolet-A-induced erythema.
Ibbotson SH; Dawe RS; Farr PM
J Invest Dermatol; 2001 May; 116(5):813-5. PubMed ID: 11348476
[TBL] [Abstract][Full Text] [Related]
10. Improved prediction of the minimal phototoxic dose in PUVA therapy.
Sakuntabhai A; Matthews JN; Farr PM
Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
[TBL] [Abstract][Full Text] [Related]
12. The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion.
Man I; Kwok YK; Dawe RS; Ferguson J; Ibbotson SH
Arch Dermatol; 2003 Mar; 139(3):331-4. PubMed ID: 12622625
[TBL] [Abstract][Full Text] [Related]
13. [Technical experience with 8-methoxypsoralen photochemotherapy in common psoriasis].
Hofmann C; Plewig G; Braun-Falco O
Hautarzt; 1976 Jun; 27(6):277-85. PubMed ID: 950302
[TBL] [Abstract][Full Text] [Related]
14. Prediction of minimal erythema dose with a reflectance melanin meter.
Damian DL; Halliday GM; Barnetson RS
Br J Dermatol; 1997 May; 136(5):714-8. PubMed ID: 9205504
[TBL] [Abstract][Full Text] [Related]
15. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of PUVA bath phototoxicity.
Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
[TBL] [Abstract][Full Text] [Related]
17. Melanin differentially protects from the initiation and progression of threshold UV-induced erythema depending on UV waveband.
Phan TA; Halliday GM; Barnetson RS; Damian DL
Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):174-80. PubMed ID: 16869864
[TBL] [Abstract][Full Text] [Related]
18. Minimal erythema dose after multiple UV exposures depends on pre-exposure skin pigmentation.
Henriksen M; Na R; Agren MS; Wulf HC
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):163-9. PubMed ID: 15238093
[TBL] [Abstract][Full Text] [Related]
19. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
20. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
